0001104659-21-133625.txt : 20211103 0001104659-21-133625.hdr.sgml : 20211103 20211103160242 ACCESSION NUMBER: 0001104659-21-133625 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211102 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gutch Michael CENTRAL INDEX KEY: 0001687333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38670 FILM NUMBER: 211375259 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA, INC. STREET 2: 50 MILK STREET, 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc. CENTRAL INDEX KEY: 0001724344 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824592913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 810-0120 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Entasis Therapeutics Ltd DATE OF NAME CHANGE: 20171204 4 1 tm2131811-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-11-02 0 0001724344 Entasis Therapeutics Holdings Inc. ETTX 0001687333 Gutch Michael C/O ENTASIS THERAPEUTICS HOLDINGS INC., 35 GATEHOUSE DRIVE WALTHAM MA 02451 0 1 0 0 CFO and Chief Business Officer Common Stock 2021-11-02 4 F 0 3669 2.94 D 42572 D Represents shares withheld solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on November 2, 2021. The number of shares withheld was determined based on the closing price on the last trading day prior to vesting, which was November 1, 2021. Michael Gutch 2021-11-03